(A) The incidence of OME in the VA group compared to the non-VA group. (B) The rate of tympanostomy tube insertion in the VA group and non-VA group. by Miki Kashiwagi (21439684)

Subjects:

The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of DALYs in 2021; (b) The EAPC of DA... by Juanjuan Li (399633)

Subjects:

Percent mortality (mean± SE) of aphid populations from four agroecological zones after ten days of exposure to six entomopathogenic fungal isolates in the laboratory at a concentra... by Aime Cheoh Enoh (20141758)

Table 1_Dexmedetomidine decreases cerebral hyperperfusion syndrome incidence following mechanical thrombectomy in acute ischemic stroke: a double-blind, randomized controlled trial... by Ziwen Gao (11627802)

Table 2_Dexmedetomidine decreases cerebral hyperperfusion syndrome incidence following mechanical thrombectomy in acute ischemic stroke: a double-blind, randomized controlled trial... by Ziwen Gao (11627802)

Table 3_Dexmedetomidine decreases cerebral hyperperfusion syndrome incidence following mechanical thrombectomy in acute ischemic stroke: a double-blind, randomized controlled trial... by Ziwen Gao (11627802)

Table 1_Association between decreased taurine levels in the anterior cingulate cortex and restricted and repetitive behaviors in autism spectrum disorder: a cross-sectional study.d... by Akihiro Minami (756085)

The technical route of the study. by Hongliang Zou (20707270)

Subjects:

Point cloud fusion instance effect. by Hongliang Zou (20707270)

Subjects:

Experimental results in the SubT-MRS dataset. by Hongliang Zou (20707270)

Subjects:

Disruption of the <i>pcnB</i> gene encoding poly(A) polymerase PAP I decreases pYV PCN as well as T3SS expression and activity. by Katherine Schubert (5452712)

Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 11 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 10 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

A summary of calibration standards (n = 3). by Ewa Paszkowska (21246702)

Subjects:

PRV UL4 is a promotor of NLRP3 inflammasome activation. by Xiaohua Zhang (350570)

Subjects:

PRV UL4 is a promotor of NLRP3 inflammasome Activation. by Xiaohua Zhang (350570)

Subjects:

Significantly Enriched Pathways. by Jiyong Zhang (2498740)

“…Pathway analysis revealed a marked decrease in expression within certain key metabolic pathways (such as the one-carbon pool by folate) in the NAFLD group, while expression in DNA repair-related pathways (such as non-homologous end joining) was significantly increased. …”

Mean persistence (±SE) of GO and GO-GA NPs on <i>Callosobruchus maculatus.</i> by Huda H. Elbehery (22492996)